ÂÜÀòÂÒÂ×

Thomas Brennan is a highly experienced individual who has held significant roles in various biotechnology companies. With a PhD in Biomedical Sciences from The University of Texas Health Science Center at Houston and a Bachelor of Arts in Microbiology and Genetic Engineering from UC Santa Barbara, Thomas has a strong educational background. Thomas served as Vice President of Pharmacology at FivePrime Therapeutics Inc. from June 2005 to January 2019, and as CEO and Co-Founder of Toccata Therapeutics Inc. from June 2003 to April 2005. Prior to that, Thomas worked as a Senior Scientist at Deltagen Inc. from May 1997 to June 2003.